Selected Publications

Academic Article

Year Title Altmetric
2019 Clear cell papillary renal cell carcinoma: molecular profile and virtual karyotypeHuman Pathology.  91:52-60. 2019
2019 Effects of Improved DNA Integrity by Punch from Tissue Blocks as Compared to Pinpoint Extraction from Unstained Slides on Next-Generation Sequencing Quality MetricsJournal of Materials Science.  152:27-35. 2019
2019 Spindle Epithelial Tumor with Thymus-Like Differentiation (SETTLE): A Next-Generation Sequencing StudyHead and Neck Pathology.  13:162-168. 2019
2019 Randomized trial of weight loss in primary breast cancer: Impact on body composition, circulating biomarkers and tumor characteristicsInternational Journal of Cancer2019
2019 Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood SamplesIn C. Kenner and J. McGrath, Eds. Developmental care of newborns and infants: A guide for health professionals. Philadelphia: Elsevier2019
2018 First-line treatment of widely metastatic BRAF-mutated salivary duct carcinoma with combined BRAF and MEK inhibitionJournal of the National Comprehensive Cancer Network.  16:1166-1170. 2018
2018 Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary InterventionJACC: Cardiovascular Interventions.  11:181-191. 2018
2017 Comparison of two point-of-care cyp2c19 genotyping assays for genotype-guided antiplatelet therapyJournal- Royal College of Surgeons Edinburgh.  47:738-743. 2017
2017 Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet TherapyJACC: Basic to Translational Science.  102:493-501. 2017
2017 Immunogenomics: using genomics to personalize cancer immunotherapyVirchows Archiv.  471:209-219. 2017
2017 Detection of chromosomal translocation in hematologic malignancies by a novel DNA-based Looped Ligation Assay (LOLA)Journal of the Reticuloendothelial Society.  63:1278-1287. 2017
2017 Alterations of type II classical cadherin, cadherin-10 (CDH10), is associated with pancreatic ductal adenocarcinomasGenes, Chromosomes and Cancer.  56:427-435. 2017
2017 Alchemy: A web 2.0 real-time quality assurance platform for human immunodeficiency Virus, hepatitis C Virus, and BK Virus quantitation assaysJournal of Pathology Informatics.  8. 2017
2017 Differential gene expression in ductal carcinoma in situ of the breast based on ERBB2 statusJournal of education for social work.  24:102-110. 2017
2017 Hepatitis C virus Genie: A web 2.0 interpretation and analytics platform for the Versant Hepatitis C virus genotype Line Probe Assay version 2.0Journal of Pathology Informatics.  8. 2017
2017 Implementation and utilization of the molecular tumor board to guide precision medicineOncotarget.  8:57845-57854. 2017
2016 Primary Colon Adenosquamous Carcinoma in a Patient with Lynch Syndrome: A New Histologic Subtype Associated with Microsatellite Instability?International Journal of Surgical Pathology.  24:653-655. 2016
2016 Is low positive JAK2 V617F mutation test result clinically significant?: Multi-institutional studyBehavioral Sciences and the Law.  24:589-594. 2016
2016 ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breastOncotarget.  7:80655-80663. 2016
2015 Poor cell block adequacy rate for molecular testing improved with the addition of Diff-Quik-stained smears: Need for better cell block processingEquine Veterinary Journal.  123:480-487. 2015
2015 Frozen section: Guiding the hands of surgeons?Expert Opinion on Drug Discovery.  19:326-329. 2015
2014 Clinicopathological and molecular features of myeloid sarcoma as initial presentation of therapy-related myeloid neoplasms: a single institution experienceInternational Journal of Hematology.  100:457-463. 2014
2013 Overview of molecular genetic diagnosisInformation Resources Management Journal2013
2013 RNA isolation from mammalian samplesインターナショナルナーシング・レビュー2013
2013 DNA isolation from Mammalian samplesインターナショナルナーシング・レビュー2013
2012 Molecular pathology and molecular markers of ductal carcinoma in-situParallel Algorithms and Applications.  8:197-204. 2012
2012 A virtual pyrogram generator to resolve complex pyrosequencing resultsJournal of Molecular Diagnostics.  14:149-159. 2012
2011 Analysis of hematopoietic stem cell transplant engraftment: Use of loss or gain of microsatellite alleles to identify residual hematopoietic malignancyAccounting Education.  20:194-202. 2011
2011 EGFR and KRAS mutations in metastatic lung adenocarcinomasHuman Pathology.  42:1447-1453. 2011
2011 The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive diseaseJournal of Surgical Oncology.  104:458-465. 2011
2011 Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: Superior results compared with microsatellite analysisJournal of Molecular Diagnostics.  13:541-548. 2011
2011 Δ-PCR, a simple method to detect translocations and insertion/deletion mutationsJournal of Molecular Diagnostics.  13:85-92. 2011
2010 Specimen identity testing using deoxyribonucleic acid analysis in clinical and surgical pathology settingPathology Case Reviews.  15:116-120. 2010


Year Title Altmetric
2015 Molecular pathology of osteosarcoma.  213-222. 2015

Education And Training

  • Doctor of Medicine, University of Tokyo Health Sciences 1985
  • Hahnemann University Hospital, Residency 2008
  • University of Tokyo Faculty of Medicine, Residency 1987
  • Johns Hopkins Hospital, Postdoctoral Fellowship 2011
  • University of Pennsylvania Hospital, Postdoctoral Fellowship 2009
  • University of Tokyo Faculty of Medicine, Postdoctoral Fellowship 1990
  • Full Name

  • Shuko Harada